Skip to main content

Table 1 Demographics, clinical, and ocular characteristics of subjects in controls and PACG groups

From: Impact of rs11024102 PLEKHA7, rs3753841 COL11A1 single nucleotide polymorphisms, and serum levels of oxidative stress markers on the risk of primary angle-closure glaucoma in Egyptians

 

Control group (n=35)

PACG group (n=64)

T value/χ2 value

P value

Age (years)

56.71±6.79

59.77±8.10

−1.89

0.061

Gender n (%)

 Male

14 (40)

36 (56.2)

2.390

0.122

 Female

21 (60)

28 (43.8)

  

SBP (mm Hg)

126.49±14.18

132.75±18.03

−1.78

0.079

DBP (mm Hg)

81.06±6.40

81.47±10.88

−0.205

0.838

Pulse rate (BPM)

74.86±.6.94

78.20±9.64

−1.811

0.073

IOP average (mm Hg)

15.47±0.31

21.84±0.71

−6.47

<0.0001

DM (yes/no)

4/31

12/52

0.895

0.344

Topical glaucoma medications (yes/no)

0/35

60/4

58.617

<0.0001

Hypertension (yes/no)

6/29

21/43

2.801

0.094

Smoking (yes/no)

2/33

4/60

0.011

0.915

Intraocular surgery (yes/no)

0/35

18/46

12.03

0.001

CVD (yes/no)

1/34

7/57

1.989

0.158

  1. Data are expressed as mean ± SE for quantitative variables and frequencies (percentages) for categorical variables
  2. PACG primary closure angle glaucoma, SBP systolic blood pressure, DBP diastolic blood pressure, BMP beats per minute, IOP intraocular pressure, DM diabetes mellitus, CVD cardiovascular diseases
  3. The mean difference is significant at p<0.05